-
Verismo Therapeutics’ Trial for R/R B-NHL CAR-T SynKIR-310 Doses First Patient
14 Jan 2025 12:49 GMT
… Therapeutics’ phase 1 CELESTIAL-301 clinical trial (NCT06544265), which is evaluating … the treatment MSLN-expressing pleural mesothelioma, cholangiocarcinoma, or ovarian cancer … -in-groundbreaking-synkir-110-clinical-trial-for-advanced-cancers-301918684. …
-
Mesothelioma Patients Become Long-Term Survivors After TTFields Maintenance Therapy
31 Dec 2024 15:25 GMT
… to treat mesothelioma in 2019 following success in a clinical trial. Patients continued … to receive TTFields therapy after the trial … .
Understanding TTFields Treatment for Mesothelioma
TTFields is an innovative treatment …
-
Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
02 Dec 2024 12:08 GMT
… open-label, controlled Phase 3 clinical trial designed to test the efficacy … , multi-center Phase 2 clinical trial designed to test the safety … pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials …
-
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
02 Dec 2024 12:07 GMT
… ’s third positive Phase 3 clinical trial in the last two years … open-label, controlled Phase 3 clinical trial designed to test the efficacy … pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials …
-
Innovation in Healthcare: HTEC’s Q4 Movers & Shakers
21 Jan 2025 14:18 GMT
… such as glioblastoma and mesothelioma, with ongoing clinical trials investigating its potential applications … failure of their ovarian cancer clinical trial, NovoCure ended the year on … endpoint in a late-stage trial, demonstrating extended survival in …
-
Malignant Ascites Market Poised for Robust Growth by 2034, Says DelveInsight
21 Jan 2025 11:49 GMT
… IDE approval for a clinical trial to evaluate its … colorectal lesion removal. The trial, focusing on the … advanced or metastatic malignant pleural mesothelioma (MPM).
• Among the … visit @ Malignant Ascites Clinical Trials and Therapeutic Assessment
Table …
-
Global Opdivo nivolumab Market To Reach $11,281.56 million by 2029 With A Growth Rate Of 7.9%
21 Jan 2025 06:10 GMT
… into new geographic markets, ongoing clinical trials, a growing trend towards personalized … Lung Cancer NSCLC; Malignant Pleural Mesothelioma; Classical Hodgkin Lymphoma CHL; Squamous …
-
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
16 Dec 2024 21:43 GMT
… following complete resection.
Malignant Pleural Mesothelioma
KEYTRUDA, in combination with … advanced or metastatic malignant pleural mesothelioma (MPM).
Head and Neck … oncology. By addressing barriers to clinical trial participation, screening and treatment, …
-
Hedy Lee Kindler named Associate Dean for Clinical Science Research, Human Subjects
11 Dec 2024 02:24 GMT
… on developing innovative clinical trials for patients with mesothelioma and pancreatic cancer … many national and international clinical trials, including practice-changing studies … as Associate Dean for Clinical Science Research, Clinical Trials, from 2019 to …
-
Merck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian Cancer
09 Dec 2024 12:13 GMT
… or IIIA NSCLC.
Malignant Pleural Mesothelioma
KEYTRUDA, in combination with pemetrexed … advanced or metastatic malignant pleural mesothelioma (MPM).
Head and Neck … oncology. By addressing barriers to clinical trial participation, screening and treatment, we …
About
© 1995-2025